paclitaxel and ag-490
paclitaxel has been researched along with ag-490 in 5 studies
Research
Studies (5)
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 2 (40.00) | 29.6817 |
2010's | 3 (60.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors
Authors | Studies |
---|---|
Bellows, DS; Clarke, ID; Diamandis, P; Dirks, PB; Graham, J; Jamieson, LG; Ling, EK; Sacher, AG; Tyers, M; Ward, RJ; Wildenhain, J | 1 |
Austin, CP; Fidock, DA; Hayton, K; Huang, R; Inglese, J; Jiang, H; Johnson, RL; Su, XZ; Wellems, TE; Wichterman, J; Yuan, J | 1 |
Pal, S; Sainis, KB; Shankar, BS | 1 |
Li, H; Wu, J; Xu, Y; Zhang, J; Zhong, S | 1 |
Chen, L; Chen, YT; Cui, JY; Liu, BW; Wang, L; Zhang, F | 1 |
Other Studies
5 other study(ies) available for paclitaxel and ag-490
Article | Year |
---|---|
Chemical genetics reveals a complex functional ground state of neural stem cells.
Topics: Animals; Cell Survival; Cells, Cultured; Mice; Molecular Structure; Neoplasms; Neurons; Pharmaceutical Preparations; Sensitivity and Specificity; Stem Cells | 2007 |
Genetic mapping of targets mediating differential chemical phenotypes in Plasmodium falciparum.
Topics: Animals; Antimalarials; ATP Binding Cassette Transporter, Subfamily B, Member 1; Chromosome Mapping; Crosses, Genetic; Dihydroergotamine; Drug Design; Drug Resistance; Humans; Inhibitory Concentration 50; Mutation; Plasmodium falciparum; Quantitative Trait Loci; Transfection | 2009 |
Cytokines from the tumor microenvironment modulate sirtinol cytotoxicity in A549 lung carcinoma cells.
Topics: Apoptosis; Benzamides; Cell Line, Tumor; Cell Survival; Cisplatin; Cytokines; Drug Resistance, Neoplasm; ErbB Receptors; Humans; Insulin-Like Growth Factor I; Janus Kinases; Lung Neoplasms; Molecular Targeted Therapy; Naphthols; Paclitaxel; Phosphatidylinositol 3-Kinases; Receptor, IGF Type 1; Receptors, TNF-Related Apoptosis-Inducing Ligand; Receptors, Tumor Necrosis Factor; Sirtuin 1; TNF-Related Apoptosis-Inducing Ligand; Transforming Growth Factor beta; Tumor Microenvironment; Tumor Necrosis Factor-alpha; Tyrphostins | 2013 |
Inhibition of JAK2 Reverses Paclitaxel Resistance in Human Ovarian Cancer Cells.
Topics: Antineoplastic Agents, Phytogenic; Apoptosis; ATP Binding Cassette Transporter, Subfamily B, Member 1; Cell Proliferation; Dose-Response Relationship, Drug; Drug Resistance, Neoplasm; Enzyme Inhibitors; Female; G2 Phase Cell Cycle Checkpoints; Gene Expression Regulation, Neoplastic; Humans; Janus Kinase 2; M Phase Cell Cycle Checkpoints; Ovarian Neoplasms; Paclitaxel; Phosphorylation; RNA, Messenger; RNA, Small Interfering; Signal Transduction; STAT2 Transcription Factor; Transduction, Genetic; Tyrphostins; Up-Regulation | 2015 |
CAFs enhance paclitaxel resistance by inducing EMT through the IL‑6/JAK2/STAT3 pathway.
Topics: Cell Line, Tumor; Cell Movement; Cell Proliferation; Cells, Cultured; Coculture Techniques; Drug Resistance, Neoplasm; Epithelial-Mesenchymal Transition; Female; Fibroblasts; Humans; Interleukin-6; Janus Kinase 2; Neoplasm Grading; Neoplasm Staging; Ovarian Neoplasms; Paclitaxel; Retrospective Studies; STAT3 Transcription Factor; Tyrphostins | 2018 |